BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27494903)

  • 41. [Determination of the antibacterial and antiviral activity of the essential oil from Minthostachys verticillata (Griseb.) Epling].
    Primo V; Rovera M; Zanon S; Oliva M; Demo M; Daghero J; Sabini L
    Rev Argent Microbiol; 2001; 33(2):113-7. PubMed ID: 11494754
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro antibacterial activity of poly (amidoamine)-G7 dendrimer.
    Gholami M; Mohammadi R; Arzanlou M; Akbari Dourbash F; Kouhsari E; Majidi G; Mohseni SM; Nazari S
    BMC Infect Dis; 2017 Jun; 17(1):395. PubMed ID: 28583153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and antibacterial activities of acylide derivatives bearing an aryl-tetrazolyl chain.
    Shan LX; Sun PH; Guo BQ; Xu XJ; Li ZQ; Sun JZ; Zhou SF; Chen WM
    Drug Des Devel Ther; 2014; 8():1515-25. PubMed ID: 25284984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of macrolides on airway microbiome and cytokine of children with bronchiolitis: A systematic review and meta-analysis of randomized controlled trials.
    Zhang Y; Dai J; Jian H; Lin J
    Microbiol Immunol; 2019 Sep; 63(9):343-349. PubMed ID: 31283028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation and Function of Interferon-Lambda (IFNλ) and Its Receptor in Asthma.
    Krammer S; Sicorschi Gutu C; Grund JC; Chiriac MT; Zirlik S; Finotto S
    Front Immunol; 2021; 12():731807. PubMed ID: 34899691
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and antibacterial activity of a novel series of acylides: 3-O-(3-pyridyl)acetylerythromycin A derivatives.
    Tanikawa T; Asaka T; Kashimura M; Suzuki K; Sugiyama H; Sato M; Kameo K; Morimoto S; Nishida A
    J Med Chem; 2003 Jun; 46(13):2706-15. PubMed ID: 12801234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens.
    Denis A; Agouridas C; Auger JM; Benedetti Y; Bonnefoy A; Bretin F; Chantot JF; Dussarat A; Fromentin C; D'Ambrières SG; Lachaud S; Laurin P; Le Martret O; Loyau V; Tessot N; Pejac JM; Perron S
    Bioorg Med Chem Lett; 1999 Nov; 9(21):3075-80. PubMed ID: 10560728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of novel antibody-based drugs against rhinovirus infection: In vitro and in vivo results.
    Petrova NV; Emelyanova AG; Gorbunov EA; Edwards MR; Walton RP; Bartlett NW; Aniscenko J; Gogsadze L; Bakhsoliani E; Khaitov MR; Johnston SL; Tarasov SA; Epstein OI
    Antiviral Res; 2017 Jun; 142():185-192. PubMed ID: 28356234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative activities of antibiotics against intracellular non-typeable Haemophilus influenzae.
    Kratzer C; Graninger W; Macfelda K; Buxbaum A; Georgopoulos A
    Wien Klin Wochenschr; 2007; 119(9-10):297-302. PubMed ID: 17571234
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem.
    Koga T; Abe T; Inoue H; Takenouchi T; Kitayama A; Yoshida T; Masuda N; Sugihara C; Kakuta M; Nakagawa M; Shibayama T; Matsushita Y; Hirota T; Ohya S; Utsui Y; Fukuoka T; Kuwahara S
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3239-50. PubMed ID: 16048932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibacterial and antiviral evaluation of sulfonoquinovosyldiacylglyceride: a glycolipid isolated from Azadirachta indica leaves.
    Bharitkar YP; Bathini S; Ojha D; Ghosh S; Mukherjee H; Kuotsu K; Chattopadhyay D; Mondal NB
    Lett Appl Microbiol; 2014 Feb; 58(2):184-9. PubMed ID: 24118020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides.
    Drago L; De Vecchi E; Nicola L; Colombo A; Gismondo MR
    J Antimicrob Chemother; 2004 Aug; 54(2):542-5. PubMed ID: 15215227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Airway-delivered short-chain fatty acid acetate boosts antiviral immunity during rhinovirus infection.
    Antunes KH; Singanayagam A; Williams L; Faiez TS; Farias A; Jackson MM; Faizi FK; Aniscenko J; Kebadze T; Chander Veerati P; Wood L; Bartlett NW; Duarte de Souza AP; Johnston SL
    J Allergy Clin Immunol; 2023 Feb; 151(2):447-457.e5. PubMed ID: 36216081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of the unfolded protein response pathway as an antiviral approach in airway epithelial cells.
    Schögler A; Caliaro O; Brügger M; Oliveira Esteves BI; Nita I; Gazdhar A; Geiser T; Alves MP
    Antiviral Res; 2019 Feb; 162():44-50. PubMed ID: 30550797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rhinovirus-bacteria coexposure synergistically induces CCL20 production from human bronchial epithelial cells.
    Maciejewski BA; Jamieson KC; Arnason JW; Kooi C; Wiehler S; Traves SL; Leigh R; Proud D
    Am J Physiol Lung Cell Mol Physiol; 2017 May; 312(5):L731-L740. PubMed ID: 28283475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kinetics and quantification of antibacterial effects of beta-lactams, macrolides, and quinolones against gram-positive and gram-negative RTI pathogens.
    Schaper KJ; Schubert S; Dalhoff A
    Infection; 2005 Dec; 33 Suppl 2():3-14. PubMed ID: 16518706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.
    Zarogoulidis P; Papanas N; Kioumis I; Chatzaki E; Maltezos E; Zarogoulidis K
    Eur J Clin Pharmacol; 2012 May; 68(5):479-503. PubMed ID: 22105373
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trehalose-mediated autophagy impairs the anti-viral function of human primary airway epithelial cells.
    Wu Q; Jiang D; Huang C; van Dyk LF; Li L; Chu HW
    PLoS One; 2015; 10(4):e0124524. PubMed ID: 25879848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microbiological profile of telithromycin, the first ketolide antimicrobial.
    Felmingham D
    Clin Microbiol Infect; 2001; 7 Suppl 3():2-10. PubMed ID: 11523558
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-Term Azithromycin Reduces
    Taylor SL; Leong LEX; Mobegi FM; Choo JM; Wesselingh S; Yang IA; Upham JW; Reynolds PN; Hodge S; James AL; Jenkins C; Peters MJ; Baraket M; Marks GB; Gibson PG; Rogers GB; Simpson JL
    Am J Respir Crit Care Med; 2019 Aug; 200(3):309-317. PubMed ID: 30875247
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.